Divis Labs

NCC, Divi's Labs among top picks by Ajit Mishra of Religare Broking

The markets experienced a volatile session and ended nearly flat, taking a breather after three consecutive days of gains

Divi's Labs set for continued growth, valuation may cap upside: Analysts

Shares of Divis's Laboratories scaled up to 3.4 per cent at Rs 6145.60 per share on the BSE after beating street estimates in its second quarter earnings for the financial year 2024-25 (Q2FY25)

Market Today: TaMo, Asian Paints Q2; China stimulus; Niva Bupa IPO Day 3

At 6:35 AM, GIFT Nifty Futures were down 82 points at 24,136, signalling a potential negative start

Divis Labs Q2 Preview: Net profit may jump 36%, revenue by 15 YoY%

Brokerages expect Divis Labs to report a robust quarter on a year-on-year basis and sequentially

Pharma stocks soar 6% as investors respond to double dose of Good News!

Individually, shares of Laurus Labs rose up to 5.55 per cent at Rs 517.90 per share, Akums Drugs and Pharmaceuticals shares locked in 5 per cent upper circuit at Rs 910.55 a piece

Divi's Labs shares jump 5% as US court stays FDA approval for Entresto drug

Shares of Divi's Laboratories surged up to 5 per cent at Rs 4960 per share on the BSE in Wednesday's intraday deals

BSE Healthcare hits new high; rallies 10% in 1 month on strong outlook

Solara Active Pharma Sciences, Indoco Remedies, Dishman Carbogen Amcis, Krishna Institute of Medical Sciences, Divi's Lab, Strides Pharma, Narayana Hrudayalaya and Vijaya Diagnostic were up 5 per cent

Buy ideas for June 11: Apollo Hospitals, Infy, Divi's Labs; key levels here

On the daily chart, Apollo Hospitals has formed a double bottom pattern at the 200-day Exponential Moving Average (DEMA), which is considered a strong support level

Buy ideas for May 30: Metro Brands, Divi's Labs; check target prices

Since April 2024, Metro Brands has been trading within a consolidation range of approximately Rs 1,020 to Rs 1,120

Divi's Labs jumps 6% on stellar Q4; brokerages upgrade target prices

Divi's Labs net profits rose by 67 per cent to Rs 538 crore in the January-March quarter of FY24 compared to Rs 321 crore in the corresponding period last year

Power Grid, Jubilant FoodWorks, Divi's: Top 3 technical picks for May 9

In the current market scenario, a significant event is unfolding within Power Grid

Positional trend on Nifty is bearish, resistance at 16,200: HDFC Securities

It would be advisable to trade longs with trailing stop loss. Support for the index is seen at 15,800.

Stocks to Watch: Aurobindo, Divi's, PTC, Sun Tv, Muthoot Fin, realty shares

Realty stocks on the back of PAG taking a contra call on the sector and corporate earnings will be in focus today

Divi's Labs reports 13% jump in net profit at Rs 557 cr in Q1

Total income rose to Rs 1,997 crore in the first quarter as compared with Rs 1,748 crore in the June quarter

Cipla, Dr Reddy's Labs: Tech charts show up to 11% upside in pharma stocks

After hitting a new all-time high of Rs 997 earlier today, the stock of Cipla is all set to rally towards Rs 1,100

Here is a Bull Spread Strategy on Divi's Labs by Nandish Shah of HDFC Sec

The short term trend is positive where the stock is trading above its 5-, 20- and 50-day EMA

Trading ideas by Ajit Mishra of Religare Broking: Buy Divi's Labs, Nalco

Most metal stocks are trading at their record highs and showing no sign of slowing down

Stocks to watch: BPCL, Britannia, PNB, Mrs Bectors Food, Divi's Labs, Affle

PNB plans to raise Rs 3,200 crore from share sale during the current quarter to enhance its capital base

Stock calls by Nilesh Jain of Anand Rathi: Buy Pidilite, Godrej Industries

Pidilite's stock is in a secular uptrend and has formed a bullish Harami candlestick pattern on the daily chart

Here is a Bull Spread Strategy on Divi's Lab by Nandish Shah of HDFC Sec

Short covering was seen in the Divi's Lab Futures' where we have seen 1 per cent fall in the Open Interest with price rising by 3 per cent